OK
The Universal Selection Source:
Coatings Ingredients
Industry News

President and CEO of Boston Scientific is Featured Plenary Speaker at SPE-ANTEC 2005 in Boston

Published on 2005-04-04. Author : SpecialChem

Brookfield, CT - The Society of Plastics Engineers (SPE) announced that James Tobin, president and CEO of Boston Scientific Corporation, will be the second plenary speaker to address the 2005 attendees at the 63rd SPE-ANTEC in Boston, Massachusetts.

SPE-ANTEC takes place May 1-5, 2005 in Boston at the Hynes Convention Center.

Tobin will speak on the subject of "Polymer Technology Helping to Revolutionize Treatment of Cardiovascular Disease," which will take place at 11 a.m. on Tuesday, May 3, at the Hynes Convention Center.

"Mr. Tobin's presentation will explain the development of the transformational polymer technology used to develop the TAXUS system-the largest selling coronary stent system in the world today," explains Karen Winkler, president of SPE.

What is the TAXUS System, and How Will it Improve the Treatment of Cardiovascular Disease?

Developed by Boston Scientific Corporation (BSC), the TAXUS system has revolutionized the treatment of coronary artery disease by dramatically reducing the incidence of vessels re-clogging and therefore, the need for re-treatment.

The BSC polymer is an elastomeric block copolymer known as poly(styrene-b-isobutylene-b-styrene)-also called SIBS-that was originally developed for industrial applications. It was later identified by BSC as an extremely biocompatible material with ideal properties for a coronary stent coating and drug delivery matrix. Since the polymer was not commercially available when BSC undertook its drug-eluting stent development work, the company joined with the University of Massachusetts, Lowell to design and implement a process to produce the polymer to support clinical trials and commercialization of the TAXUS system.

Tobin's presentation will include a description of the partnerships that helped BSC develop this polymer technology, as well as the key features that make it an ideal candidate for this demanding application.

About SPE

The Society of Plastics Engineers, Inc. (SPE) is the premier source of peer-reviewed technical information for plastics professionals. Originally incorporated in 1942, SPE takes action every day to help companies in the plastics industry succeed by spreading knowledge, strengthening skills and promoting plastics. Employing these vital strategies, SPE has helped the plastics industry thrive for over 60 years. SPE has become the recognized medium of communication among scientists, engineers and technical personnel engaged in the development, conversion and application of plastics.

About James R. Tobin

Jim Tobin joined Boston Scientific Corporation as president and CEO in 1999, bringing with him health care industry leadership and vision that helps the company build on its dramatic growth. With approximately 14,000 employees worldwide, the company develops, manufactures and markets less-invasive medical devices for use in a broad range of interventional medical specialties.

Before joining Boston Scientific, Tobin was president and CEO of Biogen, Inc. He managed the company's research and development, manufacturing, marketing and sales. Tobin joined Biogen as president and chief operating officer in 1994 and became president and CEO in 1997. He also served on the company's Board of Directors.

Previously, Jim spent 22 years with Baxter International, rising from financial analyst to president and CEO. Between 1972 and 1994, he served as Managing Director in Japan (1975-1977) and Spain (1977-1980), and President of the I.V. Systems Group (1981-1986). He was promoted to executive vice president, responsible for running a worldwide business group, in 1988 and became responsible for Baxter's manufacturing and distribution business in 1990. He served as president and chief operating officer of the 60,000-employee, $9 billion company from 1992 until 1994.

Jim serves on the boards of Boston Scientific Corporation, Applera Corporation, Curis, Inc., Beth Israel Deaconess Medical Center, Inc. and is involved with the BioMedical Science Career Program. He also served as lieutenant in the U. S. Navy from 1968 to 1972.

He holds an A.B. from Harvard College and an M.B.A. from Harvard Business School.

Source: The Society of Plastics Engineers (SPE)


Channel Alerts

Receive weekly digests on hot topics

Back to Top